| HOME >> BIOLOGY >> TECHNOLOGY |
(In thousands, except per share data)
(Unaudited)
Three Months Ended Nine Months Ended
September 30, September 30,
2008 2007 2008 2007
REVENUES:
Sales $489,664 $428,729 $1,408,603 $1,287,802
Other revenues 8,818 9,692 25,813 34,865
498,482 438,421 1,434,416 1,322,667
COSTS AND EXPENSES:
Cost of sales 121,477 82,258 312,711 251,970
Research and development 88,325 93,527 250,169 274,078
Selling, general and
administrative 222,948 186,456 631,832 527,962
Settlement reserve 7,450 369,000 7,450 425,000
Restructuring charges 1,497 - 6,973 -
In-process research and
development - - 10,000 -
441,697 731,241 1,219,135 1,479,010
INCOME (LOSS) FROM
OPERATIONS 56,785 (292,820) 215,281 (156,343)
OTHER INCOME (EXPENSE):
Interest income 4,002 8,868 15,515 23,485
Interest expense (8,831) (5,660) (25,697) (15,272)
Gain on extinguishment of
debt - 5,319 - 5,319
Gain on sale of investment - - - 5,791
Other income (expense), net (2,284) 2,493 1,488 3,747
(7,113) 11,020 (8,694) 23,070
INCOME (LOSS) BEFORE INCOME
TAXES
'/>"/>
| SOURCE Cephalon, Inc. Copyright©2008 PR Newswire. All rights reserved |